applejacklover97 t1_is6s6nk wrote
If you’re like me and immediately wondered “can they do something about it when they find it? why exactly are they looking?” here’s what the paper notes as the use for this data:
> Identifying pre-diagnostic functional and cognitive changes could improve selection for preventive and early disease-modifying treatment trials.
ETA: Just realized this is covered in OP’s comment, but I want to keep the quote from the article up anyway. Super cool stuff. My grandpa has Parkinson’s. Thanks for posting OP :)
Anustart15 t1_is8hedj wrote
As someone that has worked in neurodegeneration research, the ability to set up trials to actually start treating someone very very early into onset, it would be much easier to see efficacy.
Viewing a single comment thread. View all comments